Ergomed Group is a prominent provider of specialized services to the pharmaceutical and biotechnology industries. With a dedicated focus on clinical research, pharmacovigilance, and GxP audits, Ergomed is committed to supporting the development of new drugs and enhancing patient outcomes globally.
| Service | Description |
|---|---|
| Ergomed Clinical Research | A full-service Clinical Research Organization (CRO) focused on oncology, rare diseases, and complex trials, providing end-to-end solutions for clinical development. |
| PrimeVigilance | Offers comprehensive pharmacovigilance (PV) and medical information (MI) services from clinical development through to post-marketing, ensuring the safety and efficacy of drugs. |
| ADAMAS Consulting | Provides a full range of GxP audits covering all phases from early development to post-marketing surveillance, ensuring compliance and quality across the lifecycle of medicinal products. |
With a footprint in approximately 100 countries, Ergomed Group is uniquely positioned to manage complex projects and meet the demanding needs of its clients. Our team is dedicated to responsible business practices and corporate social responsibility, aligning with our mission to not only advance clinical research but also improve patients' lives globally.
At Ergomed, our success hinges on our people. We invite passionate individuals to join our unique company as we strive to improve patient lives through innovative drug development.
For queries or to learn more about our services, feel free to reach out to our offices in the UK or US. We look forward to partnering with you in advancing healthcare.